Clinical Trials in North Carolina

Showing 1421-1440 of 20,428 trials

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

NCT05858034

The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).

HIVAging

Wake Forest University Health Sciences100 participantsStarted Jun 2023

Winston-Salem, North Carolina, United States

Active Not RecruitingNA41 miles

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Ischemic StrokeSystemic Embolism

AtriCure, Inc.6,573 participantsStarted Jan 2023

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +135 more locations

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Find Trials by Condition in North Carolina

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Neuroblastoma Biology Study

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

Long Term Follow-up for RGX-202

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

Open Nipple Sparing Mastectomy (NSM)

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms